Cardiology

Numerous complications associated with diabetes, including the risk of death, begin at the pre-diabetic stage.

Findings from a recently published meta-analysis of patients with pre-diabetes, with and without ASCVD, suggest an increased risk for premature death and cardiovascular events.

The FDA has given a Fast Track Designation to accelerate study of Farxiga’s effect on reduction in mortality and heart failure after a heart attack.

The use of statins in veterans 75 years or older was associated with an overall reduced risk of morbidity and mortality.

Explore the detriments associated with two of the most common diabetes comorbidities.

Study finds proportions of carbs, proteins and fats in the diet have differing effects on mortality risk for men and women with type 2.

The new HbA1c variability score (HVS) allows HbA1c variability to be more easily and consistently studied.

 Why are younger patients with diabetes not seeing the same improvements as those over 45? 

Hypertension, obesity, and diabetes found to be the most prevalent comorbidities among 5700 hospitalized patients with COVID-19 in the New York City Area. 

The familiarity of using hemoglobin A1C value to guide control in patients with type 2 diabetes is known, but how do these longitudinal values relate to cardiovascular outcomes?